FDA-approved LLLT for hair loss: 15% increased hair density in 48 weeks. Proven for men and women. Panacea ATP Pro Series.

Hair loss affects both men and women. Low-Level Light Therapy (LLLT) with red light is one of the best-substantiated non-surgical treatments, with FDA approval.

FDA Approved

The FDA approved LLLT for men in 2007 and for women in 2011.

Clinical Results

A 48-week trial (Dermatologic Therapy, 2026) showed: hair density increased from 99.2 to 124.2 hairs per cm2 and hair thickness increased from 65.1 to 74.9 micrometers - approximately 15% improvement. RNA sequencing analysis confirmed that 650 nm is the most effective wavelength for hair growth stimulation.

How does it work?

Red light at 650 nm is absorbed by cytochrome c oxidase in hair follicle cells, increasing ATP production and activating transcription factors that promote cell growth. The ATP Pro Series includes 630 nm and 660 nm in the therapeutic range, supplemented with near-infrared for improved scalp circulation.

Shin et al. (2026). Long-Term Efficacy and Safety of LLLT for Androgenetic Alopecia. Dermatologic Therapy.

Hair Growth Promoting Effects of 650 nm Red Light (PMC, 2021)

Role of Low-Level Light Therapy in Androgenetic Alopecia (PMC, 2022)